HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease.

AbstractOBJECTIVE:
To examine the distribution of HLA class II alleles in clinically distinct juvenile rheumatoid arthritis (JRA) subsets.
METHODS:
We typed 298 patients and 181 controls for HLA-DRB1, DQA1, DQB1, and DPB1 alleles using polymerase chain reaction and oligonucleotide probe techniques.
RESULTS:
Each JRA subset was characterized by a distinct distribution of HLA class II alleles. For the persistently pauciarticular and rheumatoid factor-negative polyarticular JRA subsets, certain combinations of DRB1 and DPB1 alleles were characteristic. In patients without antinuclear antibodies and chronic iridocyclitis, there was an increase of DRB1*0101/02 and DQA1*0101.
CONCLUSION:
Findings of HLA typing support clinical subdivisions of the disease and suggest the existence of a novel DRB1*0101/02 and DQA1*0101 associated disease subset.
AuthorsR Ploski, O Vinje, K S Rønningen, A Spurkland, D Sørskaar, F Vartdal, O Førre
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 36 Issue 4 Pg. 465-72 (Apr 1993) ISSN: 0004-3591 [Print] United States
PMID8457222 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antinuclear
  • HLA-DP Antigens
  • HLA-DQ Antigens
  • HLA-DQ alpha-Chains
  • HLA-DQA1 antigen
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class II
Topics
  • Aging (genetics)
  • Alleles
  • Antibodies, Antinuclear (blood)
  • Arthritis, Juvenile (epidemiology, genetics, immunology)
  • Child
  • Child, Preschool
  • Female
  • HLA-DP Antigens
  • HLA-DQ Antigens (genetics)
  • HLA-DQ alpha-Chains
  • HLA-DR Antigens (genetics)
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class II (genetics)
  • Histocompatibility Testing
  • Humans
  • Infant
  • Iridocyclitis (blood, immunology)
  • Male
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: